BALA MOHAN (SVP, Chief Development Officer) sold 2.6% of their position (77.00 shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $762.30 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/28/2025ACC: 0001104659-25-103170
Officer· SVP, Chief Development Officer
Since Sep 2023
-77.00
Net shares
Net seller
$762.30
Total sold
1
Open market trades
0B · 1S
3
Total transactions
250.00 acquired · 327.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+250.00
Price / share
—
Trade value
—
% of position
9.1%
10/25/2025
2.75K→3K
Common Stock
Direct
Shares
−77.00
Price / share
$9.90
Trade value
$762.30
% of position
2.6%
10/27/2025
3K→2.92K
Total
Net shares
+173.00
Net value
-$762.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2025 | M · Option Exercise | +250.00 | — | — | 9.1% | 2.75K | 3K |
| Common Stock Direct | 10/27/2025 | S · Sale | −77.00 | $9.90 | $762.30 | 2.6% | 3K | 2.92K |
| Total | +173.00 | -$762.30 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
250.00 shares
Shares
−250.00
Strike price
Held after
0.00
Exercisable
—
10/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock250.00 shares | 10/25/2025 | M · Option Exercise | −250.00 | — | 0.00 |